Mesoblast Limited vs Invesco WilderHill Clean Energy ETF — how do they compare? Mesoblast Limited trades at $16.38 (market cap $2.17B), while Invesco WilderHill Clean Energy ETF trades at $34.21. Which is the better fit depends on your goals.
| MESO | PBW | |
|---|---|---|
Market Cap | $2.17B | — |
Sector | Technology | Sector/Thematic |
52-Week High | $20.96 | $46.99 |
52-Week Low | $12.88 | $22.23 |
Enterprise Value | $2.17B | — |
Trailing returns across standard periods
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →PBW is an equal-weighted ETF that invests in U.S. companies leading the clean energy transition. It focuses on renewable energy, power conservation, and sustainable technologies like solar, wind, and energy storage.
Read more on PBW →